Nitec Pharma AG is a pharmaceutical company recently established in Switzerland as a spin-out of Merck KGaA of Darmstadt, Germany. The company focuses on the development of anti-inflammatory drugs with an improved benefit-risk profile for patients suffering from chronic inflammatory diseases. Nitec’s approach will result in easier-to-use and more effective products in a field of high medical need.